SGMO: Sangamo Analyst Target Range

Symbol and logo of brand Sangamo (SGMO)

Sangamo Therapeutics (SGMO) is developing an advanced environment for gene modification, utilizing AI services for deep integration into the research cycles of major pharmaceutical behemoths. This price action chart on GURU.Markets captures the 3.75 metric. The team is led by genomic therapy pioneers focused on fundamental discoveries. B2B contracts ensure financial stability, while the pace of clinical trials is constrained by strict FDA oversight.

SGMO Sangamo: Price Target Chart in the range 07/04/2022 - 05/09/2026

Metric breakdowns and analytics for Sangamo Therapeutics, Inc. (SGMO)

General company analysis:SGMO Sangamo Therapeutics Inc.
Manufactured products of sangamo.com

The scale of innovation in genome editing by Sangamo Therapeutics (SGMO) is reflected in the aggregate target price history on the GURU.Markets platform. This indicator aggregates discounted cash flow model calculations from leading banks, allowing investors to use a weighted average fundamental valuation to decouple market volatility from the real impact of the company's unique patent portfolio on the asset's long-term potential.

Competitors of Sangamo Therapeutics

Analyst Forecast Prices TEM|Analyst Consensus Forecast QGEN (Qiagen NV)|Isis Pharmaceuticals (IONS) - Average Forecast Price|Repligen Corp - Analyst Consensus Forecast|RNA - Analyst Consensus Forecast|CRISPR Therapeutics AG (CRSP) - Price Target Chart|Broker Consensus Forecast WGS|RARE (Ultragenyx Pharmaceutical) - Analyst Consensus Forecast|Broker Consensus Forecast BEAM (Beam Tx)|Price Target Chart Sarepta (SRPT)|Twist Bioscience - Broker Consensus Forecast|Analyst Consensus Forecast TXG (10x Genomics, Inc.)|Analyst Consensus Forecast Intellia Therapeutics, Inc. NTLA|STOK - Price Target Chart|BLFS: Price Target Chart|WVE (Wave Life Sciences) - Consensus Target|Maze Therapeutics (MAZE) - Analyst Consensus Forecast|Price Target Chart Sionna Corp|Prime Medicine Inc (PRME) - Analyst Median Target|Price Target Chart Taysha Corp (TSHA)|uniQure N.V. (QURE) - Analyst Target Range|Analyst Consensus Forecast MGTX (MeiraGTx Corp)|RGNX: Broker Consensus Forecast|SLDB: Consensus Target|OCGN (Ocugen Corp) - Broker Consensus Forecast|PACB: Analyst Consensus Forecast|Consensus Target Benitec Biopharma Inc.|Consensus Target DSGN|Rocket Pharmaceuticals - Forecast Levels Chart|Analyst Consensus Forecast FDMT|LXEO - Average Forecast Price|Korro Bio, Inc. - Consensus Target|EDIT: Broker Consensus Forecast|SLN - Price Target Chart|PRQR - Analyst Consensus Forecast|CDXS (Codexis, Inc.) - Consensus Target|Average Forecast Price Nautilus Biotechnology (NAUT)|MGX (Metagenomi Therapeutics) - Analyst Consensus Forecast|Average Forecast Price precisionbiosciences.com DTIL|Price Target Chart Generation Bio Co. (GBIO)|BOLD (Boundless Bio, Inc.) - Fair Value Consensus|Exicure Inc. - Consensus Target|IMNN: Broker Consensus Forecast|Phio Pharmaceuticals Corp - Analyst Consensus Forecast|Analyst Median Target Mustang Bio MBIO|RNAZ: Analyst Consensus Forecast|Bionano Genomics Inc. - Fair Value Consensus|APDN (Applied DNA Sciences Inc) - Analyst Consensus Forecast|Price Target Chart BLUE|Price Target Chart ImmunoPrecise Antibodies (IPA)|OMGA - Average Forecast Price|Singular Genomics Systems, Inc. - Consensus Target|Analyst Median Target regulusrx.com (RGLS)|SYRS - Price Target Chart|TBIO (Telesis Bio Inc.) - Broker Consensus Forecast|TRACON Pharmaceuticals, Inc (TCON) - Price Target Chart|Broker Consensus Forecast UBX